Evidence map›Paper›PMID 24613486›Full record

ArticleStructure (London, England : 1993)2014

Molecular mechanism of antibody-mediated activation of β-galactosidase.

Kutti R Vinothkumar, Greg McMullan, Richard Henderson

Open access · hybridAbstract read
In one paragraph

Article in Structure (London, England : 1993), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Antibody-mediated enzyme formation: Its legacy at age fifty-four.Journal of molecular recognition : JMR · 2021
    Review
  2. Article
  3. Sparseness and Smoothness Regularized Imaging for improving the resolution of Cryo-EM single-particle reconstruction.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  4. Article
  5. High-resolution cryo-EM proteasome structures in drug development.Acta crystallographica. Section D, Structural biology · 2017
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kutti R VinothkumarMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Greg McMullanMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.
Richard HendersonMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK. Electronic address: rh15@mrc-lmb.cam.ac.uk.
MRC Laboratory of Molecular Biology · GB

Funding

Medical Research Council MC_U105184322Medical Research Council U105184322
6 · The paper itself

Abstract

Binding of a single-chain Fv antibody to Escherichia coli β-galactosidase (β-gal) is known to stabilize the enzyme and activate several inactive point mutants, historically called antibody-mediated enzyme formation mutants. To understand the nature of this activation, we have determined by electron cryo-microscopy the structure of the complex between β-gal and the antibody scFv13R4. Our structure localizes the scFv13R4 binding site to the crevice between domains 1 and 3 in each β-gal subunit. The mutations that scFv13R4 counteracts are located between the antibody binding site and the active site of β-gal, at one end of the TIM-barrel that forms domain 3 where the substrate lactose is hydrolyzed. The mode of binding suggests how scFv stabilizes both the active site of β-gal and the tetrameric state.

Indexed as

beta-GalactosidaseCatalytic DomainEnzyme ActivationEscherichia coliEscherichia coli ProteinsGene ExpressionLactoseModels, MolecularProtein BindingProtein FoldingProtein MultimerizationProtein Structure, SecondaryProtein SubunitsRecombinant ProteinsSingle-Chain Antibodiesbeta-GalactosidaseEscherichia coli ProteinsLactoseProtein SubunitsRecombinant ProteinsSingle-Chain Antibodies

Identifiers

PMID24613486
PMCPMC3988998
OpenAlexW2104514755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.